162 related articles for article (PubMed ID: 19698822)
1. Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days.
Fjerstad M; Sivin I; Lichtenberg ES; Trussell J; Cleland K; Cullins V
Contraception; 2009 Sep; 80(3):282-6. PubMed ID: 19698822
[TBL] [Abstract][Full Text] [Related]
2. Unexpected heaping in reported gestational age for women undergoing medical abortion.
Sivin I; Trussell J; Lichtenberg ES; Fjerstad M; Cleland K; Cullins V
Contraception; 2009 Sep; 80(3):287-91. PubMed ID: 19698823
[TBL] [Abstract][Full Text] [Related]
3. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
[TBL] [Abstract][Full Text] [Related]
4. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial.
Winikoff B; Dzuba IG; Creinin MD; Crowden WA; Goldberg AB; Gonzales J; Howe M; Moskowitz J; Prine L; Shannon CS
Obstet Gynecol; 2008 Dec; 112(6):1303-1310. PubMed ID: 19037040
[TBL] [Abstract][Full Text] [Related]
5. Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study.
Lohr PA; Reeves MF; Hayes JL; Harwood B; Creinin MD
Contraception; 2007 Sep; 76(3):215-20. PubMed ID: 17707719
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
Gatter M; Cleland K; Nucatola DL
Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
[TBL] [Abstract][Full Text] [Related]
9. Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study.
Goldstone P; Michelson J; Williamson E
Med J Aust; 2012 Sep; 197(5):282-6. PubMed ID: 22938126
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion.
Chong E; Tsereteli T; Nguyen NN; Winikoff B
Contraception; 2012 Sep; 86(3):251-6. PubMed ID: 22305917
[TBL] [Abstract][Full Text] [Related]
11. Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation.
Fox MC; Creinin MD; Harwood B
Contraception; 2002 Oct; 66(4):225-9. PubMed ID: 12413616
[TBL] [Abstract][Full Text] [Related]
12. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
Guengant JP; Bangou J; Elul B; Ellertson C
Contraception; 1999 Sep; 60(3):167-72. PubMed ID: 10640161
[TBL] [Abstract][Full Text] [Related]
13. Severity of infection following the introduction of new infection control measures for medical abortion.
Fjerstad M; Trussell J; Lichtenberg ES; Sivin I; Cullins V
Contraception; 2011 Apr; 83(4):330-5. PubMed ID: 21397090
[TBL] [Abstract][Full Text] [Related]
14. Mifepristone and misoprostol for early abortion when no gestational sac is present.
Schaff EA; Fielding SL; Eisinger S; Stadalius L
Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation.
Chai J; Wong CY; Ho PC
Contraception; 2013 Apr; 87(4):480-5. PubMed ID: 23102797
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone and misoprostol for medical termination of pregnancy: the effectiveness of a flexible regimen.
Basu R; Gundlach T; Tasker M
J Fam Plann Reprod Health Care; 2003 Jul; 29(3):139-41. PubMed ID: 12885307
[TBL] [Abstract][Full Text] [Related]
17. Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao.
Boersma AA; Meyboom-de Jong B; Kleiverda G
Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):61-6. PubMed ID: 21303309
[TBL] [Abstract][Full Text] [Related]
18. Acceptability and feasibility of outpatient medical abortion with mifepristone and misoprostol up to 70 days gestation in Singapore.
Tan YL; Singh K; Tan KH; Gosavi A; Koh D; Abbas D; Winikoff B
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():144-147. PubMed ID: 30179732
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
Kapp N; Borgatta L; Ellis SC; Stubblefield P
Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mifepristone-buccal misoprostol for early medical abortion in an Australian clinical setting.
Goldstone P; Walker C; Hawtin K
Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):366-371. PubMed ID: 28303569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
